[Discussion] we are measuring 503B at the wrong time and calling it noise
Posting this as a discussion rather than a claim: we are measuring 503B at the wrong time and calling it noise. Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label. A beyond-use date derived from published…
503A or 503B — do you know which?
Added a jurisdiction tag — the answers to this question are completely different in different countries.
Added a jurisdiction tag — the answers to this question are completely different in different countries.
Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.
do not assume the concentration matches the branded product
Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.
the label on a compounded vial is a legal document, read it
a 503B has to register and report, so there is a paper trail to ask for
salt forms are the recurring argument and the answer is boring
a telehealth intake that asks nothing has told you what it is
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
What is the beyond-use date and what is it based on?
compounded is not generic, there is no equivalence claim